N-methyl-1-(5-phenyl-1H-pyrazol-3-yl)methanamine oxalate, 95.0%, 1g

4-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carboxylic acid, 95.0%, 1g

3,5-Dichloro-4-hydroxybenzaldehyde, 97.0%, 10g

Fmoc-2-Methoxy-D-Phenylalanine, 98%, 5g

Warning symbol according to ISO 7010 Individual label, Radioactive substances or ionizing radiation, Side length 200 mm, 1 piece

4-Thiophen-2-yl-thiazol-2-ylamine, 97.0%, 2.5g

2-(4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)thiazol-2-yl)acetonitrile, 98%, 1g

4-Chloro-6,7-dimethoxy-2-methylquinazoline, 95.0%, 10g

3,5-Dichloro-N-((1-((2,2-dimethyltetrahydro-2H-pyran-4-yl)methyl)-4-fluoropiperidin-4-yl)methyl)benzamide, 97%, 1g

3-(3,4-DIMETHOXYPHENYL)-1-(3-HYDROXYPHENYL)-1-PROPANONE, 95.0%, 1g

1,2-Bis(bromomethyl)-4,5-dimethylbenzene, 98%, 1g

2-Propylvaleric Acid>99.0%(GC)(T)500mL

2-{[(2-fluorophenyl)sulfonyl]amino}-3-phenylpropanoic acid, 95.0%, 250mg